27604152|t|Characterisation of methicillin-resistant Staphylococcus aureus clinical isolates from animals in New Zealand, 2012-2013, and subclinical colonisation in dogs and cats in Auckland
27604152|a|To characterise methicillin-resistant Staphylococcus aureus (MRSA) isolates from infection sites in animals in New Zealand and assess the prevalence of subclinical MRSA colonisation in dogs and cats attending veterinary clinics in Auckland. MRSA isolates from clinical specimens obtained by the main New Zealand veterinary diagnostic laboratories between June 2012 and June 2013, were genotypically characterised by DNA microarray hybridisation analysis and spa typing. In addition, nasal or perineal skin swabs collected from a cross-sectional sample of dogs (n=361) and cats (n=225) attending 29 veterinary clinics in Auckland during the same period were analysed for MRSA by culture. Eight MRSA clinical isolates were submitted for characterisation by the participating laboratories. The isolates originated from five dogs, including two isolates from the same dog, one foal, and one isolate had no identification of the source. The strain - types identified were AK3 (ST-5 SCCmecIV t045; n=1), USA500 (ST8 SCCmecIV t064; n=1), WSPP (ST30 SCCmecIV t019; n=1), Rhine Hesse (ST5 SCCmecII t002; n=2), and EMRSA-15 (ST22 SCCmecIV t032; n=3). No MRSA were isolated from 586 cultured swabs. Methicillin-susceptible S. aureus were detected in 9/257 (3.5%) swabs and non-aureus staphylococci in 22/257 (8.5%) swabs. The estimated true MRSA subclinical colonisation prevalence was 0%, with an upper 95% CI boundary of 1.9% for cats and 1.4% for dogs. The modest number of MRSA isolates submitted for this study by the participating laboratories suggests clinical MRSA infection in animals in New Zealand continues to be sporadic. The wide variety of strain - types found mirrored the evolving strain - type diversity observed in humans. We cannot rule out bias due to the non-random sampling of dogs and cats, but the apparent colonisation prevalence of 0% was consistent with the low prevalence of subclinical colonisation in humans in New Zealand. These similarities indicate the epidemiology of animal and human MRSA infections are linked. In the last decade, the prevalence of human MRSA infections in New Zealand has steadily increased. This is the second published study of MRSA in animals in New Zealand. The results indicate clinical MRSA infection in animals remains sporadic, but the diversification of the strain - types may pose new therapeutic challenges to veterinarians, due to their diverse resistome.
27604152	0	16	Characterisation	T052	C1880022
27604152	20	63	methicillin-resistant Staphylococcus aureus	T007	C1265292
27604152	64	72	clinical	T080	C0205210
27604152	73	81	isolates	T123	C1764827
27604152	87	94	animals	T008	C0003062
27604152	98	109	New Zealand	T083	C0027978
27604152	126	137	subclinical	T080	C0205211
27604152	138	150	colonisation	T033	C2242741
27604152	154	158	dogs	T015	C0012984
27604152	163	167	cats	T015	C0007450
27604152	171	179	Auckland	UnknownType	C0681784
27604152	183	195	characterise	T052	C1880022
27604152	196	239	methicillin-resistant Staphylococcus aureus	T007	C1265292
27604152	241	245	MRSA	T007	C1265292
27604152	247	255	isolates	T123	C1764827
27604152	261	276	infection sites	T047	C0578491
27604152	280	287	animals	T008	C0003062
27604152	291	302	New Zealand	T083	C0027978
27604152	318	328	prevalence	T081	C0220900
27604152	332	343	subclinical	T080	C0205211
27604152	344	361	MRSA colonisation	T033	C2242741
27604152	365	369	dogs	T015	C0012984
27604152	374	378	cats	T015	C0007450
27604152	389	407	veterinary clinics	T073,T093	C2936717
27604152	411	419	Auckland	UnknownType	C0681784
27604152	421	425	MRSA	T007	C1265292
27604152	426	434	isolates	T123	C1764827
27604152	440	448	clinical	T080	C0205210
27604152	449	458	specimens	T167	C0370003
27604152	480	491	New Zealand	T083	C0027978
27604152	492	526	veterinary diagnostic laboratories	T073,T093	C0022877
27604152	535	539	June	T079	C3829443
27604152	549	553	June	T079	C3829443
27604152	565	592	genotypically characterised	T052	C1880022
27604152	596	633	DNA microarray hybridisation analysis	T063	C1522053
27604152	638	641	spa	T116,T129,T130	C0038164
27604152	642	648	typing	T059	C0087124
27604152	663	668	nasal	T023	C0222095
27604152	672	685	perineal skin	T023	C0222176
27604152	686	691	swabs	T167	C0183753
27604152	709	731	cross-sectional sample	T167	C0370003
27604152	735	739	dogs	T015	C0012984
27604152	752	756	cats	T015	C0007450
27604152	778	796	veterinary clinics	T073,T093	C2936717
27604152	800	808	Auckland	UnknownType	C0681784
27604152	825	831	period	T079	C1948053
27604152	837	845	analysed	T062	C0936012
27604152	850	854	MRSA	T007	C1265292
27604152	858	865	culture	T059	C2242979
27604152	873	877	MRSA	T007	C1265292
27604152	878	886	clinical	T080	C0205210
27604152	887	895	isolates	T123	C1764827
27604152	915	931	characterisation	T052	C1880022
27604152	953	965	laboratories	T073,T093	C0022877
27604152	971	979	isolates	T123	C1764827
27604152	1001	1005	dogs	T015	C0012984
27604152	1021	1029	isolates	T123	C1764827
27604152	1044	1047	dog	T015	C0012984
27604152	1053	1057	foal	T015	C3669731
27604152	1067	1074	isolate	T123	C1764827
27604152	1104	1110	source	T033	C0449416
27604152	1116	1122	strain	T001	C1518614
27604152	1125	1130	types	T080	C0332307
27604152	1131	1141	identified	T080	C0205396
27604152	1147	1165	AK3 (ST-5 SCCmecIV	T007	C1265292
27604152	1178	1198	USA500 (ST8 SCCmecIV	T007	C1265292
27604152	1211	1230	WSPP (ST30 SCCmecIV	T007	C1265292
27604152	1243	1268	Rhine Hesse (ST5 SCCmecII	T007	C1265292
27604152	1285	1308	EMRSA-15 (ST22 SCCmecIV	T007	C1265292
27604152	1324	1328	MRSA	T007	C1265292
27604152	1334	1342	isolated	T169	C0205409
27604152	1352	1366	cultured swabs	T167	C0183753
27604152	1368	1401	Methicillin-susceptible S. aureus	T007	C1265292
27604152	1407	1415	detected	T033	C0442726
27604152	1432	1437	swabs	T167	C0183753
27604152	1442	1466	non-aureus staphylococci	T007	C0038170
27604152	1484	1489	swabs	T167	C0183753
27604152	1510	1514	MRSA	T007	C1265292
27604152	1515	1526	subclinical	T080	C0205211
27604152	1527	1539	colonisation	T033	C2242741
27604152	1540	1550	prevalence	T081	C0220900
27604152	1577	1579	CI	T081	C0009667
27604152	1601	1605	cats	T015	C0007450
27604152	1619	1623	dogs	T015	C0012984
27604152	1629	1642	modest number	T081	C0237753
27604152	1646	1650	MRSA	T007	C1265292
27604152	1651	1659	isolates	T123	C1764827
27604152	1679	1684	study	T170	C0085973
27604152	1706	1718	laboratories	T073,T093	C0022877
27604152	1728	1736	clinical	T080	C0205210
27604152	1737	1751	MRSA infection	T047	C0343401
27604152	1755	1762	animals	T008	C0003062
27604152	1766	1777	New Zealand	T083	C0027978
27604152	1794	1802	sporadic	T079	C0205422
27604152	1824	1830	strain	T001	C1518614
27604152	1833	1838	types	T080	C0332307
27604152	1867	1873	strain	T001	C1518614
27604152	1876	1880	type	T080	C0332307
27604152	1881	1890	diversity	T080	C1880371
27604152	1903	1909	humans	T016	C0086418
27604152	1930	1934	bias	T078	C0242568
27604152	1946	1965	non-random sampling	T062	C0150105
27604152	1969	1973	dogs	T015	C0012984
27604152	1978	1982	cats	T015	C0007450
27604152	2001	2013	colonisation	T033	C4289767
27604152	2014	2024	prevalence	T081	C0220900
27604152	2035	2050	consistent with	T078	C0332290
27604152	2059	2069	prevalence	T081	C0220900
27604152	2073	2084	subclinical	T080	C0205211
27604152	2085	2097	colonisation	T033	C2242741
27604152	2101	2107	humans	T016	C0086418
27604152	2111	2122	New Zealand	T083	C0027978
27604152	2130	2142	similarities	T080	C2348205
27604152	2156	2168	epidemiology	T091	C0014507
27604152	2172	2178	animal	T008	C0003062
27604152	2183	2188	human	T016	C0086418
27604152	2189	2204	MRSA infections	T047	C0343401
27604152	2229	2235	decade	T081	C2981279
27604152	2241	2251	prevalence	T081	C0220900
27604152	2255	2260	human	T016	C0086418
27604152	2261	2276	MRSA infections	T047	C0343401
27604152	2280	2291	New Zealand	T083	C0027978
27604152	2305	2314	increased	T081	C0205217
27604152	2345	2350	study	T170	C0085973
27604152	2354	2358	MRSA	T007	C1265292
27604152	2362	2369	animals	T008	C0003062
27604152	2373	2384	New Zealand	T083	C0027978
27604152	2407	2415	clinical	T080	C0205210
27604152	2416	2430	MRSA infection	T047	C0343401
27604152	2434	2441	animals	T008	C0003062
27604152	2450	2458	sporadic	T079	C0205422
27604152	2468	2483	diversification	T057	C0680948
27604152	2491	2497	strain	T001	C1518614
27604152	2500	2505	types	T080	C0332307
27604152	2519	2530	therapeutic	T169	C0302350
27604152	2545	2558	veterinarians	T097	C0242856
27604152	2581	2590	resistome	T028	C2945710